BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

576 related articles for article (PubMed ID: 11454711)

  • 21. The proximal promoter region of mTert is sufficient to regulate telomerase activity in ES cells and transgenic animals.
    Pericuesta E; Ramírez MA; Villa-Diaz A; Relaño-Gines A; Torres JM; Nieto M; Pintado B; Gutiérrez-Adán A
    Reprod Biol Endocrinol; 2006 Feb; 4():5. PubMed ID: 16457732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The level of telomere dysfunction determines the efficacy of telomerase-based therapeutics in a lung cancer cell line.
    Pantic M; Zimmermann S; Waller CF; Martens UM
    Int J Oncol; 2005 May; 26(5):1227-32. PubMed ID: 15809713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amplification of telomerase reverse transcriptase gene in human mammary epithelial cells with limiting telomerase RNA expression levels.
    Cao Y; Huschtscha LI; Nouwens AS; Pickett HA; Neumann AA; Chang AC; Toouli CD; Bryan TM; Reddel RR
    Cancer Res; 2008 May; 68(9):3115-23. PubMed ID: 18451136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TP53-dependent chromosome instability is associated with transient reductions in telomere length in immortal telomerase-positive cell lines.
    Schwartz JL; Jordan R; Liber H; Murnane JP; Evans HH
    Genes Chromosomes Cancer; 2001 Mar; 30(3):236-44. PubMed ID: 11170280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Relationship between human telomerase reverse transcriptase transcriptional level and telomerase activity in three ovarian cancer cell lines].
    Song Y; Kong BH; Liu PS; Ma DX; Jiang S
    Ai Zheng; 2003 May; 22(5):486-91. PubMed ID: 12753708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immortal ALT+ human cells do not require telomerase reverse transcriptase for malignant transformation.
    Sun B; Chen M; Hawks CL; Hornsby PJ
    Cancer Res; 2005 Aug; 65(15):6512-5. PubMed ID: 16061628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transient expression of wild-type or biologically inactive telomerase allows the formation of artificial telomeres in mortal human cells.
    Guiducci C; Anglana M; Wang A; Bacchetti S
    Exp Cell Res; 2001 May; 265(2):304-11. PubMed ID: 11302696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simultaneous targeting of telomeres and telomerase as a cancer therapeutic approach.
    Mo Y; Gan Y; Song S; Johnston J; Xiao X; Wientjes MG; Au JL
    Cancer Res; 2003 Feb; 63(3):579-85. PubMed ID: 12566299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression and alternative splicing pattern of human telomerase reverse transcriptase in human lung cancer cells.
    Fujiwara M; Kamma H; Wu W; Hamasaki M; Kaneko S; Horiguchi H; Matsui-Horiguchi M; Satoh H
    Int J Oncol; 2004 Apr; 24(4):925-30. PubMed ID: 15010831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of telomerase modulation in human hematopoietic progenitor cells.
    Zimmermann S; Glaser S; Ketteler R; Waller CF; Klingmüller U; Martens UM
    Stem Cells; 2004; 22(5):741-9. PubMed ID: 15342938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Knockdown of p53 combined with expression of the catalytic subunit of telomerase is sufficient to immortalize primary human ovarian surface epithelial cells.
    Yang G; Rosen DG; Mercado-Uribe I; Colacino JA; Mills GB; Bast RC; Zhou C; Liu J
    Carcinogenesis; 2007 Jan; 28(1):174-82. PubMed ID: 16829690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Repression of an alternative mechanism for lengthening of telomeres in somatic cell hybrids.
    Perrem K; Bryan TM; Englezou A; Hackl T; Moy EL; Reddel RR
    Oncogene; 1999 Jun; 18(22):3383-90. PubMed ID: 10362359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of telomerase activity in lung carcinoids is dependent on human telomerase reverse transcriptase transcription and alternative splicing and is associated with long telomeres.
    Zaffaroni N; Villa R; Pastorino U; Cirincione R; Incarbone M; Alloisio M; Curto M; Pilotti S; Daidone MG
    Clin Cancer Res; 2005 Apr; 11(8):2832-9. PubMed ID: 15837730
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TERT regulates cell survival independent of telomerase enzymatic activity.
    Cao Y; Li H; Deb S; Liu JP
    Oncogene; 2002 May; 21(20):3130-8. PubMed ID: 12082628
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential expression of full-length telomerase reverse transcriptase mRNA and telomerase activity between normal and malignant renal tissues.
    Fan Y; Liu Z; Fang X; Ge Z; Ge N; Jia Y; Sun P; Lou F; Björkholm M; Gruber A; Ekman P; Xu D
    Clin Cancer Res; 2005 Jun; 11(12):4331-7. PubMed ID: 15958614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human telomerase reverse transcriptase mRNA is highly expressed in normal breast tissues and down-regulated in ductal carcinoma in situ.
    Liu J; Baykal A; Fung KM; Thompson-Lanza JA; Hoque A; Lippman SM; Sahin A
    Int J Oncol; 2004 Apr; 24(4):879-84. PubMed ID: 15010825
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of telomerase by human cytomegalovirus.
    Strååt K; Liu C; Rahbar A; Zhu Q; Liu L; Wolmer-Solberg N; Lou F; Liu Z; Shen J; Jia J; Kyo S; Björkholm M; Sjöberg J; Söderberg-Nauclér C; Xu D
    J Natl Cancer Inst; 2009 Apr; 101(7):488-97. PubMed ID: 19318640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reconstitution of human telomerase reverse transcriptase expression rescues colorectal carcinoma cells from in vitro senescence: evidence against immortality as a constitutive trait of tumor cells.
    Dalerba P; Guiducci C; Poliani PL; Cifola I; Parenza M; Frattini M; Gallino G; Carnevali I; Di Giulio I; Andreola S; Lombardo C; Rivoltini L; Schweighoffer T; Belli F; Colombo MP; Parmiani G; Castelli C
    Cancer Res; 2005 Mar; 65(6):2321-9. PubMed ID: 15781646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of human telomerase enhances the effect of chemotherapeutic agents in lung cancer cells.
    Misawa M; Tauchi T; Sashida G; Nakajima A; Abe K; Ohyashiki JH; Ohyashiki K
    Int J Oncol; 2002 Nov; 21(5):1087-92. PubMed ID: 12370759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p57KIP2 expression and loss of heterozygosity during immortal conversion of cultured human mammary epithelial cells.
    Nijjar T; Wigington D; Garbe JC; Waha A; Stampfer MR; Yaswen P
    Cancer Res; 1999 Oct; 59(20):5112-8. PubMed ID: 10537284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.